Synthetic glycopeptide antigens for HIV vaccine design (469.1)
نویسندگان
چکیده
منابع مشابه
Synthetic tumor-associated glycopeptide antigens.
Glycopeptides with TN antigen (GalNAc)Ser/Thr and T-antigen structures (beta Gall-3GalNAc)Ser/Thr, described as tumor-associated antigens, were synthesized and coupled to bovine serum albumin. Alternatively, synthetic methods for the construction of beta-anomeric analogues of the TN and T-antigen glycopeptides were developed, aiming at antigenic structures having a varied stereochemistry of the...
متن کاملCarbohydrates and Immunology: Synthetic Oligosaccharide Antigens for Vaccine Formulation
Despite the enormous progress achieved by modern medicine, numerous diseases still have a profound impact on public health. Infectious diseases caused by a variety of microorganisms (viruses, fungi and parasites) and bacteria are a global major concern and, because of the emergence, for instance, of multidrug resistance, not only in developing countries. The development of preventative therapie...
متن کاملDesign and development of synthetic peptide antigens
Using hydrophilicity, surface probability, backbone flexibility and secondary structure parameters, antigenic sites of R-thymosins (TR), ubiquitin and gp41 envelope glycoprotein fragments of HIV1 are determined. Corresponding antigenic sites of TR,, TR,, ubiquitin and gp41 (583-623) are produced either by tryptic cleavage from the natural peptides or by solid phase peptide synthesis (FmocBu' st...
متن کاملSynthetic AIDS vaccine by targeting HIV receptor.
A class of synthetic peptide immunogens for the cell surface HIV receptor complex has been developed to elicit antibodies that block viral entry by inhibiting gp120-CD4 interaction. These peptides extend our HIV receptor-directed approach from passive immunotherapy with mAb B4 (Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 10367) to active immunization by a synthetic peptide-based vaccine. A peptide ...
متن کاملNovel Concepts for HIV Vaccine Vector Design
The unprecedented challenges of developing effective vaccines against intracellular pathogens such as HIV, malaria, and tuberculosis have resulted in more rational approaches to vaccine development. Apart from the recent advances in the design and selection of improved epitopes and adjuvants, there are also ongoing efforts to optimize delivery platforms. Viral vectors are the best-characterized...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The FASEB Journal
سال: 2014
ISSN: 0892-6638,1530-6860
DOI: 10.1096/fasebj.28.1_supplement.469.1